AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-13611728_ITM" title="Facts and information about NIH to study if supplement, possibly two other compounds, may slow Parkinson's.">NIH to study if supplement, possibly two other compounds, may slow Parkinson's.</a>

Close Set up an RSS feed that alerts you when new articles from The America's Intelligence Wire are available.

Frequently asked questions about RSS feeds

NIH to study if supplement, possibly two other compounds, may slow Parkinson's.

The America's Intelligence Wire

| February 24, 2006 | COPYRIGHT 2003 Financial Times Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(From AP Worldstream)

Byline: LAURAN NEERGAARD

The government is preparing major studies of substances that offer the hope of slowing the progression of Parkinson's disease instead of just treating its symptoms. First on the list is a dietary supplement sold without a doctor's prescription.

The National Institutes of Health is completing plans to enroll hundreds of early-stage Parkinson's patients in a study of superhigh doses of coenzyme Q-10, or CoQ10, the agency's neurology chief announced Thursday.

Some scientists theorize that CoQ10, a compound made in the body, may help preserve the nerve cells that die off in Parkinson's.

An…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


Agency probes for link to Parkinson's. (United States/Americas).(National...: Magazine article from: Chemical Week Franz, Neil August 28, 2002 700+ words
...environmental agents, including pesticides, play in the cause of Parkinson's disease. The grants respond to recent studies showing...causes symptoms in rats that closely resemble human effects of Parkinson's. A 2001 study by the University of Rochester (Rochester...


Teva Will Be Sole Promoter of AZILECT(R) for Parkinson's Disease in the United...: Press release article from: Business Wire July 12, 2006 700+ words
...rasagiline tablets) for Parkinson's disease in the United States. As a result, Teva's U...Administration (FDA) as a treatment for Parkinson's disease both as initial monotherapy in early Parkinson's disease patients and as adjunct...


Surveyed Neurologists in Both the United States and Europe Indicate That a...: Press release article from: PR Newswire April 28, 2009 700+ words
...Standard Status Through 2017 for Parkinson's Disease, According to...percent patient share in Parkinson's disease in both the United States and in Europe, according...The new report entitled Parkinson's Disease: A Transdermal...


One of the Largest-Ever Parkinson's Disease Studies Initiated Across the United...: Press release article from: PR Newswire April 5, 2007 700+ words
...time. According to the Parkinson's Disease Foundation...approximately 40,000 new cases of Parkinson's are diagnosed each year in the United States with as many as one and...have been diagnosed with Parkinson's within the past five...


Arch Development Corporation obtains United States patent.(for therapeutic...: Newspaper article from: BIOTECH Patent News January 1, 2003 700+ words
...Development Corporation (Chicago, IL) has patented methods and compositions for the therapeutic intervention of Parkinson's disease. More particularly, methods of making and sequestering dopamine are disclosed. Additionally, methods...


US FDA clears Teva's Azilect for early PD.(United states, Food and Drug...: Newspaper article from: Pharma Marketletter May 29, 2006 700+ words
...Azilect (rasagiline), the first once-daily tablet for Parkinson's disease, for use as initial monotherapy in early PD and...monotherapy had better symptom control as measured by total Unified Parkinson Disease Rating Scale over a 26-week period versus placebo...


Rise in number of young found with Parkinson's.: Newspaper article from: South China Morning Post December 3, 2001 700+ words
...could not be carried out. Parkinson's disease is a common...medical director of the National Parkinson Foundation in the United States, said clinical experience...increase in the number of young Parkinson's disease patients in the...


Research To Address Symptoms Of Early Parkinson Disease.: Newspaper article from: Drug Week February 22, 2002 700+ words
...Patients who have had Parkinson disease for fewer than 7 years...research study of the symptoms of Parkinson disease. In the United States, approximately 1.5 million...are believed to suffer from Parkinson's disease and about 50...


Research To Address Symptoms Of Early Parkinson Disease.(Brief Article): Newspaper article from: Pain & Central Nervous System Week February 18, 2002 700+ words
...Patients who have had Parkinson disease for fewer than 7 years...research study of the symptoms of Parkinson disease. In the United States, approximately 1.5 million...are believed to suffer from Parkinson's disease and about 50...


Encouraging results of new gene therapy for Parkinson's.: News wire article from: Europe Intelligence Wire October 10, 2002 700+ words
...potential for treatment of Parkinson's disease and other neurological...could be applied to humans. Parkinson's disease is the deterioration...Some 1.2 million people have Parkinson's in the United States and Canada. The disease strikes...

For more facts and information, see all results

The AccessMyLibrary advertising network includes: